Sei Investments Co. Boosts Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Sei Investments Co. grew its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 208,590 shares of the company’s stock after acquiring an additional 240 shares during the quarter. Sei Investments Co.’s holdings in Prestige Consumer Healthcare were worth $16,289,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Teacher Retirement System of Texas boosted its stake in shares of Prestige Consumer Healthcare by 17.9% during the fourth quarter. Teacher Retirement System of Texas now owns 14,682 shares of the company’s stock valued at $1,147,000 after purchasing an additional 2,224 shares during the period. Xponance Inc. boosted its position in Prestige Consumer Healthcare by 10.1% in the 4th quarter. Xponance Inc. now owns 3,570 shares of the company’s stock valued at $279,000 after buying an additional 328 shares during the period. Cibc World Markets Corp purchased a new stake in Prestige Consumer Healthcare in the 4th quarter valued at about $362,000. Corient Private Wealth LLC grew its stake in Prestige Consumer Healthcare by 331.6% in the 4th quarter. Corient Private Wealth LLC now owns 15,163 shares of the company’s stock worth $1,184,000 after acquiring an additional 11,650 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. purchased a new position in shares of Prestige Consumer Healthcare during the fourth quarter worth approximately $291,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Insider Activity at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the company’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at approximately $1,544,130. This represents a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Prestige Consumer Healthcare Trading Down 1.2 %

Shares of NYSE PBH opened at $85.01 on Friday. Prestige Consumer Healthcare Inc. has a 1-year low of $62.35 and a 1-year high of $90.04. The business has a fifty day moving average price of $83.30 and a 200 day moving average price of $78.97. The stock has a market capitalization of $4.21 billion, a P/E ratio of 19.91, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

PBH has been the subject of a number of research reports. Raymond James upgraded Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a report on Monday, December 9th. Royal Bank of Canada raised their price target on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a “sector perform” rating in a research note on Friday, March 21st. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Tuesday, March 18th. Finally, DA Davidson raised their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.